Covid-19

Monday

Katy Balls

Concern grows over South African variant

Although there’s plenty of positive vaccine news to go around, the latest government press conference offered a sobering reminder of the obstacles that remain when it comes to ensuring a successful vaccination programme. The Health Secretary said that despite recent efforts to prevent new arrivals to the UK bringing in the South African variant, random check found 11 cases that could not be linked to international travel. This means there has been community transmission.  While Hancock said there was ‘currently no evidence’ to suggest this variant is more severe, its emergence is of concern across government. The reason? The effect of vaccines on the new strain. Early data from two new coronavirus vaccine

Patrick O’Flynn Patrick O'Flynn

The EU’s vaccine debacle has finally ended the ‘People’s Vote’ myth

Of all the charges made against Brexiteers, the notion that we ‘don’t understand the modern world’ is the one that some Remainers have most often returned to; their equivalent of the boxer’s stinging jab that relentlessly wears down an opponent. In a global system increasingly dominated by a handful of big players with huge populations and land mass – the US, China, India, Russia – being a medium-sized nation in Europe without the umbrella of the EU was supposed to be a mug’s game. In the European Parliament, that arch-federalist Guy Verhofstadt would often refer to the countries of Europe as ‘dwarfs’ who needed to band together to compete in

Steerpike Steerpike

Martin Selmayr’s EU vaccine boast backfires

In the aftermath of the EU’s vaccine bungle, Brussels remains in damage limitation mode, determined to ensure that someone else gets the blame for its own crisis. But Mr S wonders whether top EU diplomat Martin Selmayr’s bid to put a positive spin on what has unfolded over the last few days was really so wise. Selmayr, who revelled in his nickname ‘the Rasputin of Brussels’ during his time serving as Jean-Claude Juncker’s aide, attempted to make a comparison between Europe’s vaccine rollout rate and that of Africa, the poorest continent on Earth. Selmayr, who now serves as the EU Commission representative in Austria, wrote: ‘The EU, thanks to the joint work of 27 governments,

Alec Marsh

Why we’ll soon look forward to a day in the office

The office, as we once knew it, is dead. Zoom has killed it; the digital genie is out of the lamp. What most of us didn’t realise before Covid – back in April 2020 – was that the closure of offices was final and that the daily commute may well be confined to the history books. Even when things return to ‘normal’ we won’t be able to uninvent remote working, and companies know it. In fact, many of them knew it before the pandemic struck. As one leading business figure told me back the early summer, Covid – by forcing remote working – allowed companies to activate a decade’s worth of mooted corporate culture change in just

Sunday

Ross Clark

One year after Brexit, Britain is reaping the benefits

A year ago today Britain awoke to a rather muted celebration – which seemed to consist largely of a bubble car driving around Parliament Square with a Union Jack in tow – ready to face up to a brave new future outside the EU. Who would have imagined then that the Observer would mark the first anniversary by running a leading article condemning the EU as ‘shambolic’ and instead praising Boris Johnson’s government for something Britain did all by itself? Of course, the Observer’s judgement is only in respect to one thing: the EU’s joint vaccination procurement programme. Nevertheless, it is something rather important, on which a great number of

Matthew Taylor

Sunday shows round-up: Liz Truss guarantees vaccine supply from EU

Liz Truss – We can guarantee UK’s vaccine supply The European Union’s attempt at vaccine procurement has not been its finest hour. Concerns about lack of supply across Europe prompted the EU Commission to consider how it might override Pfizer and AstraZeneca’s prior commitments and commandeer the output of their Belgian factories for the bloc’s own internal use. Signalling that the EU might block the export of the jabs, many of which had been intended for use in the UK, triggered an immediate backlash, and the EU eventually climbed down. The International Trade Secretary Liz Truss spoke to Andrew Marr, who asked her if she could be certain that the UK would

Daniel French

Vicars like me are struggling in lockdown

A year of living through a pandemic has taken its toll on the best of us. Vicars like me are no exception.  As a healthy and normally upbeat 52-year-old, this feeling of gloom is frighteningly new. Anecdotal stories from clergy friends tell a similar story to my own: the urge is to curl up and mask the misery with binge marathons of Netflix box sets. But this brings only short-term relief. A cursory look at social media posts show that a good number of vicars are struggling to keep it together.  The pressures on vicars come from every quarter. Some vicars have been landed with the impossible task of maintaining empty churches as elderly volunteers

Saturday

Brendan O’Neill

It’s time for Ireland to stand up to the EU

Ireland’s political class is facing a moment of truth. Following yesterday’s extraordinary events — with the EU temporarily triggering Article 16 of the Northern Ireland Protocol as part of its desperate effort to manage its self-made vaccines crisis — the Dublin elites have some serious soul-searching to do. They must now ask themselves if they are willing to be members of this institution that has just treated them with such contempt; which has just signalled in front of the entire world that it does not take Irish sovereignty or Irish democracy very seriously at all. Contempt is not too strong a word for what the EU has just done to

Friday

Ross Clark

Could this drug offer immediate protection from Covid-19?

When Donald Trump returned to the White House after a brief spell in hospital with Covid-19 last October he made a video attributing his rapid recovery to a drug he called ‘Regeneron’. ‘They call it a therapeutic drug, but to me it wasn’t therapeutic – it made me better,’ he said. ‘I call that a cure.’ Naturally, given that Trump had on a previous occasion appeared to advocate injecting humans with disinfectant, there was an element of scepticism on the part of many viewers. However, the drug he was talking about went on the receive emergency use authorisation in November from the US Food and Drug Administration. We now have

Kate Andrews Kate Andrews

The Johnson & Johnson jab is a game changer

Good vaccine news has been pouring in today — this afternoon it was the turn of the Janssen vaccine, made by US company Johnson & Johnson. An international trial, in which the vaccine was tested against various strains of the virus, has found the jab to have 66 per cent overall efficacy. This is a lower efficacy rate than the trial conducted in the United States — which found the jab to be 72 per cent effective. But the international trial was designed to test the vaccine against more aggressive strains of the virus in a bid to answer questions about the new mutations. The trail set up sites in ‘red list’

Ian Acheson Ian Acheson

The grim reality of being locked up during lockdown

What’s it like being locked up during lockdown? The latest statistics on prison safety paint a grim picture of life behind bars, which has been made worse by the pandemic. Even the good news must be caveated. Assaults on staff have reduced quite dramatically, which in any circumstances must be a good thing given a backdrop of record-breaking rates of violence until the virus struck. However, they have reduced mainly as a consequence of an unprecedented lockdown introduced to prevent the spread of Covid-19. This has dramatically reduced the time inmates spend outside their cells; as a consequence, it has rather limited the available opportunities for prisoners to knock seven bells out of

Katy Balls Katy Balls

Britain gets a boost to its vaccine programme

As the blame game gets underway in Brussels over the EU’s sluggish vaccination programme, the UK government has fresh reason for cheer: a new coronavirus jab. The Novavax vaccine has successfully completed its phase three trials — finding it to be 89 per cent effective in large-scale UK trials. This data will now be passed to the MHRA to assess whether the vaccine can be approved for UK use. While the vaccine is thought to be highly effective against the Kent strain of Covid, it is less effective against the South African variant. While it still offers some protection, Novavax is following Moderna’s lead in developing a booster shot to tackle this. The

Nick Tyrone Nick Tyrone

The EU vaccine debacle poses a dilemma for Remainers like me

There is no question about it, at least if you want to evaluate things objectively: the UK has handled Covid vaccine rollout well (at least so far) and the EU has dealt with it badly. For a Remainer like me, this raises a difficult question: does this prove that Brexit was a good idea after all? Compared to the EU27, the UK has been able to act nimbly in vaccine negotiations. While Brussels has been held up by various delays and supply issues, these have not affected the UK. This is thanks in large part to the fact that its contract with AstraZeneca was signed three months before the EU

Andy Shaw

A handy guide to Hotel Quarantine

On the one year anniversary of the arrival of the Covid virus in the UK, the government has introduced strict quarantine measures to stop the virus arriving again. The shock discovery that the virus mutates in other countries, as well as our own, has prompted the government to incarcerate travellers as they step off their plane. Robert Jenrick, the Secretary of State for Housing has added the responsibility of ‘housing people in hotel rooms against their will’ to his portfolio. This week, he said: ‘There will be a time when we will look back and say, with hindsight, that there are things the government could have done differently. But that

Thursday

James Forsyth

This is just the start of the Brussels-Britain bust-ups

This is a crucial year for the UK’s two most important relationships, I say in the magazine this week. If the Johnson/Biden diplomatic relationship has got off to a better start than expected, the same cannot be said of the post-Brexit UK/EU one. The alignment between Johnson and Biden on climate change, Russia and China is helping the alliance. This relationship should become closer still given the two side’s agreement on China, the most important geo-political issue of the decade. The EU will attempt, often in not particularly edifying ways, to assert itself as the bigger partner. Earlier this month, Kurt Campbell — who will hold the pen on Asia

Kate Andrews Kate Andrews

Germany has just undermined the EU’s vaccine argument

Germany’s vaccine committee has advised the Oxford-AstraZeneca vaccine only be given to under-65s. The announcement marks a major twist in a week of muddled vaccine reports. On Tuesday, the German newspaper Handelsblatt suggested that German officials believed the Oxford vaccine was only 8 per cent effective for the over-65 groups (no evidence has been produced to support the 8 per cent claim). It has been heavily and extensively rebuffed by both AstraZeneca and the German government. Yet the German reporter who broke the story doubled down on the claims, raising the stakes as to whether he was making precarious reporting worse, or whether the European Medicines Agency may indeed conclude that the vaccine’s efficacy is too low. As

Ross Clark Ross Clark

Is the virus retreating?

Imperial College’s React study was in the news again this morning. The latest instalment swabbed 167,642 people between 6 and 22 January and found that 2,282 of them tested positive. A weighted average suggested that 1.57 per cent of the population had the virus between those dates. The study concluded: ‘Prevalence remained high throughout, but with the suggestion of a decline at the end of the study period’. It led to reports this morning that the latest wave of the epidemic is declining only very slowly. The React study, however, seems to be increasingly out of line with government data on new infections, as picked up through the test and

Steerpike Steerpike

‘Sexist’ covid poster scrapped by the government

Another day, another Covid advertising fail for the government. Fresh from discontinuing a radio ad suggesting joggers and dog-walkers are ‘highly likely’ to have coronavirus, a ‘stay home, save lives’ poster has been pulled.  The advert, which showed women cleaning and caring for children while a man lounged on a sofa, sparked accusations of sexism. ‘It has been withdrawn and removed from the campaign. I will make clear that it does not reflect the government’s view on women which is why we have withdrawn it,’ Boris Johnson’s official spokesperson said today.  Oh dear..

Steven Barrett

The vaccine row shows the EU doesn’t understand contract law

The EU rejects ‘the logic of first-come first-serve,’ said the EU’s health commissioner Stella Kyriakides. ‘That may work at the neighbourhood butcher’s but not in contracts, and not in our advanced purchase agreements’. Contract law is an area of law I know well. And it is not a political comment to say the commissioner is wrong. We don’t know precisely what the contract between AstraZeneca and EU member states says. But the EU did publish another vaccine supply contract here. All this makes it very difficult to see what case the EU has In any would-be-case involving this contract, the EU has two massive hurdles to jump. Firstly, contractors undertake to

Constantin Eckner

The EU goes to war over the vaccine

German politics is backing Brussels in the ongoing dispute between the EU and AstraZeneca over Covid vaccine shipments. The European Union alleges that the pharma firm, which is producing the Oxford-developed vaccine, is planning to supply the UK faster and while failing to fulfil its contract with Brussels. A meeting on Wednesday between officials and representatives from the Cambridge-based company was described as ‘constructive’ but no solution was found. Meanwhile, Martin Schulz, the former president of the European Parliament and prominent German Social Democrat, called for hard action against AstraZeneca. ‘This company is heavily dominated by the Brits and has apparently clear priorities as to which countries it supplies,’ he said. ‘If that is